PRTK
Price:
$2.23
Market Cap:
$127.83M
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co....[Read more]
Industry
Biotechnology
IPO Date
2009-02-03
Stock Exchange
NASDAQ
Ticker
PRTK
According to Paratek Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.66. This represents a change of 37.04% compared to the average of 2.67 of the last 4 quarters.
The mean historical Current Ratio of Paratek Pharmaceuticals, Inc. over the last ten years is 12.81. The current 3.66 Current Ratio has changed 2.76% with respect to the historical average. Over the past ten years (40 quarters), PRTK's Current Ratio was at its highest in in the December 2013 quarter at 38.19. The Current Ratio was at its lowest in in the June 2023 quarter at 0.52.
Average
12.81
Median
8.25
Minimum
3.66
Maximum
38.19
Discovering the peaks and valleys of Paratek Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.78%
Maximum Annual Current Ratio = 38.19
Minimum Annual Increase = -74.35%
Minimum Annual Current Ratio = 3.66
Year | Current Ratio | Change |
---|---|---|
2022 | 3.66 | -24.69% |
2021 | 4.86 | -29.07% |
2020 | 6.85 | -31.86% |
2019 | 10.06 | -30.23% |
2018 | 14.41 | 50.78% |
2017 | 9.56 | 47.70% |
2016 | 6.47 | -6.84% |
2015 | 6.95 | -74.35% |
2014 | 27.09 | -29.07% |
2013 | 38.19 | 7.09% |
The current Current Ratio of Paratek Pharmaceuticals, Inc. (PRTK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.12
5-year avg
7.97
10-year avg
12.81
Paratek Pharmaceuticals, Inc.’s Current Ratio is greater than Selecta Biosciences, Inc. (1.33), greater than Corvus Pharmaceuticals, Inc. (0.92), less than Immutep Limited (13.81), less than Icosavax, Inc. (18.06), less than Lyra Therapeutics, Inc. (0), greater than Equillium, Inc. (3.64), greater than HOOKIPA Pharma Inc. (3.04), greater than LianBio (3.26), less than Jasper Therapeutics, Inc. (10.06), less than Affimed N.V. (7.61), greater than Leap Therapeutics, Inc. (1.93), less than Adaptimmune Therapeutics plc (3.97), less than Aptose Biosciences Inc. (3.85), greater than null (1.05),
Company | Current Ratio | Market cap |
---|---|---|
1.33 | $135.20M | |
0.92 | $314.86M | |
13.81 | $304.51M | |
18.06 | $769.04M | |
0 | $11.28M | |
3.64 | $22.88M | |
3.04 | $18.30M | |
3.26 | $34.47M | |
10.06 | $325.68M | |
7.61 | $18.88M | |
1.93 | $111.51M | |
3.97 | $148.11M | |
3.85 | $14.88M | |
1.05 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paratek Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Paratek Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Paratek Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Paratek Pharmaceuticals, Inc. (PRTK)?
What is the highest Current Ratio for Paratek Pharmaceuticals, Inc. (PRTK)?
What is the 3-year average Current Ratio for Paratek Pharmaceuticals, Inc. (PRTK)?
What is the 5-year average Current Ratio for Paratek Pharmaceuticals, Inc. (PRTK)?
How does the current Current Ratio for Paratek Pharmaceuticals, Inc. (PRTK) compare to its historical average?